What is Transmedics Group Inc Annual Revenue?

Transmedics Group Inc Annual Revenue rose 82.74%, in the last year to $441.54 M. Its sector's average revenue growth for the last fiscal year was 8.71%.

What is Transmedics Group Inc Annual Net Profit?

Transmedics Group Inc Annual Net Profit rose 241.7% in the last year to $35.46 M. Its sector's average net profit growth for the last fiscal year was 3.43%.

What is Transmedics Group Inc Price to Earning Ratio?

Transmedics Group Inc Price to Earning Ratio is 67.84, higher than its sector PE ratio of 31.4.

What is Transmedics Group Inc Stock Price?

Transmedics Group Inc Stock Price rose 0.86% and underperformed its sector by 6.77% in the past year.

What is Transmedics Group Inc Quarterly Revenue?

Transmedics Group Inc Quarterly Revenue rose 49.83% YoY to $121.62 M. Its sector's average revenue growth YoY for the quarter was 8.69%.

What is Transmedics Group Inc Quarterly Net profit?

Transmedics Group Inc Quarterly Net profit rose 70.11% YoY to $6.86 M. Its sector's average net profit growth YoY for the quarter was 26.62%.

What is Transmedics Group Inc Debt to Equity Ratio?

Transmedics Group Inc Debt to Equity Ratio of 2.27 is higher than 1. This implies that company assets are financed through debt.

What is Transmedics Group Inc Return on Equity(ROE)?

Transmedics Group Inc Return on Equity(ROE) for the last financial year was 19.39%, in the normal range of 10% to 20%.

What is Transmedics Group Inc Mutual Fund Holding?

Transmedics Group Inc Mutual Fund Holding increased by 1.43% in the last quarter to 89.72.

What is Transmedics Group Inc Promoter Share Holding?

Transmedics Group Inc Promoter Share Holding increased by 0.46% in the most recent quarter to 2.36%.

What is Transmedics Group Inc Interest Coverage Ratio?

Transmedics Group Inc Interest Coverage Ratio is 3.48, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Transmedics Group Inc Institutional Holding?

Transmedics Group Inc Institutional Holding remained the same in the last quarter at 115.33%.

How is the Transmedics Group Inc today?

The Transmedics Group Inc today is trading in the green, up by 3.50% at 71.47.

How has Transmedics Group Inc performed historically?

The Transmedics Group Inc is currently trading up 3.50% on an intraday basis in the past week the index rose 4.29%. The index has been up 12.87% in the past quarter and rose 0.86% in the past year. You can view this in the overview section.

Transmedics Group Inc XNAS: TMDX

Transmedics Group Inc Live Share Price Today, Share Analysis and Chart

Name: Transmedics Group Inc: Is Infosys Ltd. worth buying?
Item: Transmedics Group Inc
Rating: 2.5604445
Author: Trendlyne DVM scores

Falling Comet

Download real time

71.47 2.42 (3.50%)

59.71% Fall from 52W High

737.4K XNAS Volume

XNAS 24 Mar, 2025 5:30 PM (EDT)

Transmedics Group Inc Key Metrics

My Metrics

Default

Market Capitalization Below industry Median Unavailable in chosen country	2,405.8
PE TTM High in industry Unavailable in chosen country	67.8
PEG TTM Below industry Median Unavailable in chosen country	0.3
Price to Book High in industry Unavailable in chosen country	10.5
Institutional holding current Qtr % High in industry Unavailable in chosen country	115.3
Revenue Growth Qtr YoY % High in industry Unavailable in chosen country	49.8
Operating Revenue growth TTM % High in industry Unavailable in chosen country	82.7
Net Profit Qtr Growth YoY % High in industry Unavailable in chosen country	70.1
Net Profit TTM Growth % High in industry Unavailable in chosen country	241.7
Operating Profit Margin Qtr % Below industry Median Unavailable in chosen country	7.1
Operating Profit Margin TTM % Below industry Median Unavailable in chosen country	8.5
Piotroski Score High in industry Unavailable in chosen country	7
Rel Perf vs Sector quarter% Unavailable in chosen country	10.4
ROE Annual % High in industry Unavailable in chosen country	19.4
RoA Annual % Below industry Median Unavailable in chosen country	4.7

All financials are in USD Million and price data in USD

High Financial Strength

77.8 / 100

Expensive Valuation

19.0 / 100

Technically Bearish

30.3 / 100

Falling Comet These stocks are with good financial quality. But, their bad valuation and technical aspects make the investor think before investing. View Similar Embed DVM

103

1Yr Price target upside is 44%

7 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Buy Zone

23.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Transmedics Group Inc Stock Price Analysis

Day Price Range 3.5% 1 Day return Unavailable in chosen country	71.5 (LTP) 69.472.8 LowHigh
Week Price Range 4.3% 1 Week return Unavailable in chosen country	71.5 (LTP) 65.272.8 LowHigh
Month Price Range -0.7% 1 Month return Unavailable in chosen country	71.5 (LTP) 62.180.2 LowHigh
52 Week Price Range 0.9% 1 Year return Unavailable in chosen country	71.5 (LTP) 55177.4 LowHigh

View full Share Price History

Transmedics Group Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Transmedics Group Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

Avg. Estimate

1.4

Low Estimate

1.3

High Estimate

1.6

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 42.6% in FY25

Consensus Recommendation

9 ANALYST Recommendations

BUY

The consensus recommendation from 9 analysts for Transmedics Group Inc is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Transmedics Group Inc Stock Analysis

Transmedics Group Inc stock analysis with key metrics, changes, and trends.

Transmedics Group Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$441.54 M	82.74%	positive	Annual Revenue rose 82.74%, in the last year to $441.54 M. Its sector's average revenue growth for the last fiscal year was 8.71%.
Annual Net Profit	$35.46 M	241.7%	positive	Annual Net Profit rose 241.7% in the last year to $35.46 M. Its sector's average net profit growth for the last fiscal year was 3.43%.
Price to Earning Ratio	67.84	-	negative	Price to Earning Ratio is 67.84, higher than its sector PE ratio of 31.4.
Stock Price	$71.47	0.86%	negative	Stock Price rose 0.86% and underperformed its sector by 6.77% in the past year.
Quarterly Revenue	$121.62 M	49.83%	positive	Quarterly Revenue rose 49.83% YoY to $121.62 M. Its sector's average revenue growth YoY for the quarter was 8.69%.
Quarterly Net profit	$6.86 M	70.11%	positive	Quarterly Net profit rose 70.11% YoY to $6.86 M. Its sector's average net profit growth YoY for the quarter was 26.62%.
Debt to Equity Ratio	2.27	-	negative	Debt to Equity Ratio of 2.27 is higher than 1. This implies that company assets are financed through debt.
Return on Equity(ROE)	19.39 %	19.39%	neutral	Return on Equity(ROE) for the last financial year was 19.39%, in the normal range of 10% to 20%.
Mutual Fund Holding	89.72 %	1.43%	positive	Mutual Fund Holding increased by 1.43% in the last quarter to 89.72.
Promoter Share Holding	2.36 %	0.46%	positive	Promoter Share Holding increased by 0.46% in the most recent quarter to 2.36%.
Interest Coverage Ratio	3.48	-	positive	Interest Coverage Ratio is 3.48, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	115.33 %	0%	neutral	Institutional Holding remained the same in the last quarter at 115.33%.

VIEW LESS

Loading data..

Transmedics Group Inc - Company Profile

What does Transmedics Group Inc do?

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Gross Remuneration

2024

Gross Remuneration

Year

Transmedics Group Inc Live Share Price Today, Share Analysis and Chart

59.71% Fall from 52W High

Transmedics Group Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Transmedics Group Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Transmedics Group Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Transmedics Group Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to grow by 42.6% in FY25

Consensus Recommendation

The consensus recommendation from 9 analysts for Transmedics Group Inc is BUY

Transmedics Group Inc Stock Analysis

Transmedics Group Inc stock analysis with key metrics, changes, and trends.

Annual Revenue rose 82.74%, in the last year to $441.54 M. Its sector's average revenue growth for the last fiscal year was 8.71%.

Annual Net Profit rose 241.7% in the last year to $35.46 M. Its sector's average net profit growth for the last fiscal year was 3.43%.

Price to Earning Ratio is 67.84, higher than its sector PE ratio of 31.4.

Stock Price rose 0.86% and underperformed its sector by 6.77% in the past year.

Quarterly Revenue rose 49.83% YoY to $121.62 M. Its sector's average revenue growth YoY for the quarter was 8.69%.

Quarterly Net profit rose 70.11% YoY to $6.86 M. Its sector's average net profit growth YoY for the quarter was 26.62%.

Debt to Equity Ratio of 2.27 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE) for the last financial year was 19.39%, in the normal range of 10% to 20%.

Mutual Fund Holding increased by 1.43% in the last quarter to 89.72.

Promoter Share Holding increased by 0.46% in the most recent quarter to 2.36%.

Interest Coverage Ratio is 3.48, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding remained the same in the last quarter at 115.33%.

Transmedics Group Inc - Company Profile

What does Transmedics Group Inc do?

Transmedics Group Inc Management structure

Mr. Stephen Gordon

Chief Financial Officer and Treasurer

Mr. Gerardo Hernandez

Chief Financial Officer and Treasurer

Dr. Waleed Hassanein, M.D.

President, Chief Executive Officer and Director

Transmedics Group Inc Board of directors

Mr. Edwin M. Kania, Jr.

Independent Director

Mr. James R. Tobin

Chairman of the Board

Ms. Merilee Raines

Independent Director

Mr. Thomas J. Gunderson